Clinical Trial Update: A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1B study evaluating safety and preliminary efficacy of Dasatinib in combination with Nivolumab in Chronic Myeloid Leukemia has been completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2019-01-17